Announcement on Voluntary Disclosure of Ethical Review Approval for Phase II Clinical Trial of Antivenom Serum against Viper Venom
· Issued by Shanghai Serum Bio-technology Co., Ltd. Class A via Shanghai Stock Exchange
Announcement on Voluntary Disclosure of Ethical Review Approval for Phase II Clinical Trial of Antivenom Serum against Viper Venom
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
View AttachmentCompany analysis
